More recently, high expression of the IL7 receptor (IL7R) in BCP-ALL cells from bone marrow/peripheral blood at diagnosis were shown to be associated with a positive CNS status and a higher risk for CNS relapse in patients [36]. This evidence concerns the gene IL7R and acute lymphoblastic leukemia.